Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-18

Clinical Trial Update: Feasibility Trial for a Right Ventricular Failure Platform Trial [Phase 2]

View source ↗

Summary

Phase 2 feasibility platform trial assessing right ventricular failure in pulmonary hypertension; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Pulmonary Hypertension, Right Ventricular Dysfunction | Phase 2 | Status: RECRUITING